Female sexual dysfunction in postmenopausal women

Bibliography

• DRENCH ME, LOSEE RH: Sexuality and sexual capacities of elderly people. Rehabil. Nurs. (1996) 21(3):118-123.
   PubMedGoogle Scholar
• KADRI N, BERRADA S, ALAMI KM et al.: Mental health of Moroccan women, a sexual perspective. J. Affect. Disord. (2006)
   Google Scholar
• PHILLIPS NA: Female sexual dysfunction: evaluation and treatment. Am. Fam. Physician (2000) 62(1):127-136, 141-122.
   PubMed Web of Science ®Google Scholar
• WYLIE KR: Sexuality and the menopause. J. Br. Menopause Soc. (2006) 12(4):149-152.
   PubMedGoogle Scholar
• DE LORENZI DR, BARACAT EC, SACILOTO B, PADILHA I JR: Factors related to quality of life in post-menopause. Rev. Assoc. Med. Bras. (2006) 52(5):312-317.
   PubMedGoogle Scholar
• BORISSOVA AM, KOVATCHEVA R, SHINKOV A: Changes in sexual behavior in Bulgarian women after the menopause. Gynecol. Endocrinol. (2000) 14(6):448-453.
   PubMed Web of Science ®Google Scholar
• AVIS NE, STELLATO R, CRAWFORD S, JOHANNES C, LONGCOPE C: Is there an association between menopause status and sexual functioning? Menopause (2000) 7(5):297-309.
   PubMed Web of Science ®Google Scholar
• BLUMEL JE, CASTELO-BRANCO C, BINFA L et al.: Quality of life after the menopause: a population study. Maturitas (2000) 34(1):17-23.
   PubMed Web of Science ®Google Scholar
• MURRAY W: Decreased libido in postmenopausal women. Nurse Pract. Forum (2000) 11(4):219-224.
   PubMedGoogle Scholar
• LAUMANN EO, PAIK A, ROSEN RC: Sexual dysfunction in the United States: prevalence and predictors. Jama (1999) 281(6):537-544.
   PubMed Web of Science ®Google Scholar
• CASTELO-BRANCO C, BLUMEL JE, ARAYA H et al.: Prevalence of sexual dysfunction in a cohort of middle-aged women: influences of menopause and hormone replacement therapy. J. Obstet. Gynaecol. (2003) 23(4):426-430.
   PubMedGoogle Scholar
• YANEZ D, CASTELO-BRANCO C, HIDALGO LA, CHEDRAUI PA: Sexual dysfunction and related risk factors in a cohort of middle-aged Ecuadorian women. J. Obstet. Gynaecol. (2006) 26(7):682-686.
   PubMedGoogle Scholar
• BLUMEL JE, CASTELO-BRANCO C, CANCELO MJ et al.: Impairment of sexual activity in middle-aged women in Chile. Menopause (2004) 11(1):78-81.
   PubMed Web of Science ®Google Scholar
• MCCOY NL: Methodological problems in the study of sexuality and the menopause. Maturitas (1998) 29(1):51-60.
   PubMed Web of Science ®Google Scholar
• MCCOY NL: Longitudinal study of menopause and sexuality. Acta. Obstet. Gynecol. Scand. (2002) 81(7):617-622.
   PubMed Web of Science ®Google Scholar
• CASTELO-BRANCO C, VICENTE JJ, FIGUERAS F et al.: Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas (2000) 34(2):161-168.
   PubMed Web of Science ®Google Scholar
• SAFARINEJAD MR: Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors. Int. J. Impot. Res. (2006) 18(4):382-395.
   PubMed Web of Science ®Google Scholar
• AVIS NE, ZHAO X, JOHANNES CB et al.: Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women's Health Across the Nation (SWAN). Menopause (2005) 12(4):385-398.
   PubMed Web of Science ®Google Scholar
• DHILLON HK, SINGH HJ, GHAFFAR NA: Sexual function in menopausal women in Kelantan, Malaysia. Maturitas (2005) 52(3-4):256-263.
   PubMed Web of Science ®Google Scholar
• DENNERSTEIN L, LEHERT P: Women's sexual functioning, lifestyle, mid-age, and menopause in 12 European countries. Menopause (2004) 11(6 Pt 2):778-785.
   PubMed Web of Science ®Google Scholar
• PARK YJ, KIM HS, CHANG SO, KANG HC, CHUN SH: Sexuality and related factors of postmenopausal Korean women. Taehan Kanho Hakhoe Chi (2003) 33(4):457-463.
   PubMedGoogle Scholar
• DENNERSTEIN L, ALEXANDER JL, KOTZ K: The menopause and sexual functioning: a review of the population-based studies. Annu. Rev. Sex Res. (2003) 14:64-82.
   PubMedGoogle Scholar
• LEIBLUM SR, KOOCHAKI PE, RODENBERG CA, BARTON IP, ROSEN RC: Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause (2006) 13(1):46-56.
   PubMed Web of Science ®Google Scholar
• DENNERSTEIN L, KOOCHAKI P, BARTON I, GRAZIOTTIN A: Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. J. Sex Med. (2006) 3(2):212-222.
   PubMed Web of Science ®Google Scholar
• CASTELO-BRANCO C, CANCELO MJ, VILLERO J, NOHALES F, JULIA MD: Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas (2005) 52(Suppl. 1):S46-S52.
   Google Scholar
• BACHMANN G, BANCROFT J, BRAUNSTEIN G et al.: Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil. Steril. (2002) 77(4):660-665.
   PubMed Web of Science ®Google Scholar
• PARK K, GOLDSTEIN I, ANDRY C et al.: Vasculogenic female sexual dysfunction: the hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. Int. J. Impot. Res. (1997) 9(1):27-37.
   PubMed Web of Science ®Google Scholar
• DE LORENZI DR, SACILOTO B: Factors related to frequency of sexual activity of postmenopausal women. Rev. Assoc. Med. Bras. (2006) 52(4):256-260.
   PubMedGoogle Scholar
• SIERRA B, HIDALGO LA, CHEDRAUI PA: Measuring climacteric symptoms in an Ecuadorian population with the Greene Climacteric Scale. Maturitas (2005) 51(3):236-245.
   PubMed Web of Science ®Google Scholar
• KIRCHENGAST S: Effect of socioeconomic factors on timing of menopause and the course of climacteric. Z. Gerontol. (1992) 25(2):128-133.
   PubMed Web of Science ®Google Scholar
• BLUMEL JE, CASTELO-BRANCO C, RIQUELME R et al.: Use of hormone replacement therapy among Chilean women: a comparison between socioeconomic levels. Menopause (2002) 9(5):377-380.
   PubMed Web of Science ®Google Scholar
• KHAN N: Sexual and physical abuse: a threat to reproductive and sexual health. Sex Health Exch. (1998) 1:1-3.
   Google Scholar
• SUAREZ-AL-ADAM M, RAFFAELLI M, O'LEARY A: Influence of abuse and partner hypermasculinity on the sexual behavior of Latinas. AIDS Educ. Prev. (2000) 12(3):263-274.
   PubMed Web of Science ®Google Scholar
• BOTROS SM, ABRAMOV Y, MILLER JJ et al.: Effect of parity on sexual function: an identical twin study. Obstet. Gynecol. (2006) 107(4):765-770.
   PubMed Web of Science ®Google Scholar
• ASLAN G, KOSEOGLU H, SADIK O et al.: Sexual function in women with urinary incontinence. Int. J. Impot. Res. (2005) 17(3):248-251.
   PubMed Web of Science ®Google Scholar
• MAAS CP, WEIJENBORG PT, TER KUILE MM: The effect of hysterectomy on sexual functioning. Annu. Rev. Sex Res. (2003) 14:83-113.
   PubMedGoogle Scholar
• AZIZ A, BERGQUIST C, NORDHOLM L, MOLLER A, SILFVERSTOLPE G: Prophylactic oophorectomy at elective hysterectomy. Effects on psychological well-being at 1-year follow-up and its correlations to sexuality. Maturitas (2005) 51(4):349-357.
   PubMed Web of Science ®Google Scholar
• MESTON CM: Aging and sexuality. West J. Med. (1997) 167(4):285-290.
   PubMedGoogle Scholar
• CHEDRAUI P, HIDALGO L, CHAVEZ D et al.: Menopausal symptoms and associated risk factors among postmenopausal women screened for the metabolic syndrome. Arch. Gynecol. Obstet. (2007) 275(3):161-168.
   PubMedGoogle Scholar
• FELDMAN HA, GOLDSTEIN I, HATZICHRISTOU DG, KRANE RJ, McKINLAY JB: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol. (1994) 151(1):54-61.
   PubMed Web of Science ®Google Scholar
• JOHANNES CB, ARAUJO AB, FELDMAN HA et al.: Incidence of erectile dysfunction in men 40 –69 years old: longitudinal results from the Massachusetts male aging study. J. Urol. (2000) 163(2):460-463.
   PubMed Web of Science ®Google Scholar
• COCORES JA, MILLER NS, POTTASH AC, GOLD MS: Sexual dysfunction in abusers of cocaine and alcohol. Am. J. Drug Alcohol Abuse (1988) 14(2):169-173.
   PubMed Web of Science ®Google Scholar
• WEST SL, VINIKOOR LC, ZOLNOUN D: A systematic review of the literature on female sexual dysfunction prevalence and predictors. Annu. Rev. Sex Res. (2004) 15:40-172.
   PubMedGoogle Scholar
• OSVATH P, FEKETE S, VOROS V, VITRAI J: Sexual dysfunction among patients treated with antidepressants – a Hungarian retrospective study. Eur. Psychiatry (2003) 18(8):412-414.
   PubMed Web of Science ®Google Scholar
• WORTHINGTON JJ III, PETERS PM: Treatment of antidepressant-induced sexual dysfunction. Drugs Today (2003) 39(11):887-896.
   PubMed Web of Science ®Google Scholar
• BERMAN JR, BASSUK J: Physiology and pathophysiology of female sexual function and dysfunction. World J. Urol. (2002) 20(2):111-118.
   PubMed Web of Science ®Google Scholar
• ROSEN R, BROWN C, HEIMAN J et al.: The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J. Sex Marital Ther. (2000) 26(2):191-208.
   PubMed Web of Science ®Google Scholar
• MILLER KK, ROSNER W, LEE H et al.: Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J. Clin.. Endocrinol. Metab. (2004) 89(2):525-533.
   PubMed Web of Science ®Google Scholar
• SARREL P, DOBAY B, WIITA B: Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses. J. Reprod. Med. (1998) 43(10):847-856.
   PubMed Web of Science ®Google Scholar
• SARREL PM: Sexuality and menopause. Obstet. Gynecol. (1990) 75(Suppl. 4):26S-30S; discussion 31S-35S.
   PubMedGoogle Scholar
• PALACIOS S, CASTELO-BRANCO C, CANCELO MJ, VAZQUEZ F: Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy. Maturitas (2005) 50(2):98-104.
   PubMed Web of Science ®Google Scholar
• CHETKOWSKI RJ, MELDRUM DR, STEINGOLD KA et al.: Biologic effects of transdermal estradiol. N. Engl. J. Med. (1986) 314(25):1615-1620.
   PubMed Web of Science ®Google Scholar
• FITZPATRICK LA, PACE C, WIITA B: Comparison of regimens containing oral micronized progesterone or medroxyprogesterone acetate on quality of life in postmenopausal women: a cross-sectional survey. J. Womens Health Gend. Based Med. (2000) 9(4):381-387.
   PubMedGoogle Scholar
• SHERWIN BB: The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J. Clin. Endocrinol. Metab. (1991) 72(2):336-343.
   PubMed Web of Science ®Google Scholar
• LAAN E, VAN LUNSEN RH, EVERAERD W: The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric (2001) 4(1):28-41.
   PubMedGoogle Scholar
• LOBO RA, ROSEN RC, YANG HM, BLOCK B, VAN DER HOOP RG: Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil. Steril. (2003) 79(6):1341-1352.
   PubMed Web of Science ®Google Scholar
• SHIFREN JL, BRAUNSTEIN GD, SIMON JA et al.: Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N. Engl. J. Med. (2000) 343(10):682-688.
   PubMed Web of Science ®Google Scholar
• BUSTER JE, KINGSBERG SA, AGUIRRE O et al.: Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet. Gynecol. (2005) 105(5 Pt 1):944-952.
   PubMed Web of Science ®Google Scholar
• SIMON J, BRAUNSTEIN G, NACHTIGALL L et al.: Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J. Clin. Endocrinol. Metab. (2005) 90(9):5226-5233.
   Google Scholar
• BRAUNSTEIN GD, SUNDWALL DA, KATZ M et al.: Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch. Intern. Med. (2005) 165(14):1582-1589.
   PubMed Web of Science ®Google Scholar
• KROLL R, DAVIS S, MOREAU M, WALDBAUM A, SHILFREN J, WEKSELMANN K: Testosterone transdermal patch significantly improves sexual function in naturally menopausal women in a large Phase III study. In: Meeting of the American Society for Reproductive Medicine (Ed.). Philadelphia, PA (2004).
   Google Scholar
• MYERS LS, DIXEN J, MORRISSETTE D, CARMICHAEL M, DAVIDSON JM: Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women. J. Clin. Endocrinol. Metab. (1990) 70(4):1124-1131.
   PubMed Web of Science ®Google Scholar
• MILLER KK, BILLER BM, BEAUREGARD C et al.: Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab. (2006) 91(5):1683-1690.
   PubMed Web of Science ®Google Scholar
• SOMBOONPORN W, DAVIS S, SEIF MW, BELL R: Testosterone for peri- and postmenopausal women. Cochrane Database Syst. Rev. (2005) 4:CD004509.
   Google Scholar
• BASSON R, BROTTO LA: Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial. Bjog (2003) 110(11):1014-1024.
   PubMed Web of Science ®Google Scholar
• CARUSO S, RUGOLO S, AGNELLO C et al.: Sildenafil improves sexual functioning in premenopausal women with Type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study. Fertil. Steril. (2006) 85(5):1496-1501.
   PubMed Web of Science ®Google Scholar
• MAYOR S: Pfizer will not apply for a licence for sildenafil for women. Bmj (2004) 328(7439):542.
   PubMedGoogle Scholar
• GITLIN MJ, SURI R, ALTSHULER L, ZUCKERBROW-MILLER J, FAIRBANKS L: Bupropion-sustained release as a treatment for SSRI-induced sexual side effects. J. Sex Marital Ther. (2002) 28(2):131-138.
   PubMed Web of Science ®Google Scholar
• ROSEN RC, PHILLIPS NA, GENDRANO NC III, FERGUSON DM: Oral phentolamine and female sexual arousal disorder: a pilot study. J. Sex Marital Ther. (1999) 25(2):137-144.
   PubMed Web of Science ®Google Scholar
• ISLAM A, MITCHEL J, ROSEN R et al.: Topical alprostadil in the treatment of female sexual arousal disorder: a pilot study. J. Sex Marital Ther. (2001) 27(5):531-540.
   PubMed Web of Science ®Google Scholar
• MESTON CM, WORCEL M: The effects of yohimbine plus L-arginine glutamate on sexual arousal in postmenopausal women with sexual arousal disorder. Arch. Sex. Behav. (2002) 31(4):323-332.
   PubMed Web of Science ®Google Scholar
• FERGUSON DM, STEIDLE CP, SINGH GS et al.: Randomized, placebo-controlled, double blind, crossover design trial of the efficacy and safety of Zestra for Women in women with and without female sexual arousal disorder. J. Sex Marital Ther. (2003) 29(Suppl. 1):33-44.
   PubMed Web of Science ®Google Scholar
• CHEN J, WOLLMAN Y, CHERNICHOVSKY T et al.: Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study. BJU Int. (1999) 83(3):269-273.
   PubMed Web of Science ®Google Scholar
• WILSON SK, DELK JR II, BILLUPS KL: Treating symptoms of female sexual arousal disorder with the Eros-Clitoral Therapy Device. J. Gend. Specif. Med. (2001) 4(2):54-58.
   PubMedGoogle Scholar
• CARUSO S, AGNELLO C, INTELISANO G et al.: Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder. Urology (2004) 63(5):955-959.
   PubMed Web of Science ®Google Scholar